Citation: Be. Lewis et al., NOVASTAN(R) ANTICOAGULATION DURING RENAL STENT IMPLANT IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA, Blood coagulation & fibrinolysis, 8(1), 1997, pp. 54-58
Authors:
LEWIS BE
GRASSMAN E
WRONA L
RANGEL Y
IQBAL O
WALENGA JM
FAREED J
Citation: Be. Lewis et al., SUCCESSFUL USE OF ARGATROBAN IN CORONARY ANGIOPLASTY IN PATIENTS WITHHEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME, Thrombosis and haemostasis, 1997, pp. 2018-2018
Authors:
GALBRAITH E
WRONA L
LEYA F
GRASSMAN E
HOPPENSTEADT D
FASANELLA A
WOLF H
Citation: E. Galbraith et al., LONG-TERM COMPLIANCE AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN IN PATIENTS TREATED WITH HIGH-DOSE CERTOPARIN FOR THE PREVENTION OF POST PTCA RESTENOSIS, Thrombosis and haemostasis, 1997, pp. 2800-2800
Authors:
LEWIS BE
MATTHAI W
GRASSMAN ED
LEYA FS
FAREED J
WALENGA JM
WRONA L
RANGEL Y
JOFFRION JL
WHITLOW PL
MCKEEVER LS
Citation: Be. Lewis et al., RESULTS OF PHASE-2 3 TRIAL OF ARGATROBAN ANTICOAGULATION DURING PTCA OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)/, Circulation, 96(8), 1997, pp. 1199-1199
Authors:
LEWIS BE
FERGUSON JJ
GRASSMAN ED
FAREED J
WALENGA J
JOFFRION JL
WRONA L
JOHNSON SA
SCHWARZ RP
MCKIERNAN T
Citation: Be. Lewis et al., SUCCESSFUL CORONARY INTERVENTIONS PERFORMED WITH ARGATROBAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS SYNDROME, The Journal of invasive cardiology, 8(9), 1996, pp. 410-417
Authors:
CALIFF RM
SHADOFF N
VALETT N
BATES E
GALEANA A
KNOPF W
SHAFTEL J
BENDER MJ
AVERSANO T
RAQUENO J
GURBEL P
COWFER J
COHEN M
CROSS P
BITTL J
EDDINGS K
TAYLOR M
DEROSA K
HATTEL L
COOPER L
ESHELMAN B
FINTEL D
NIEMYSKI P
KLEIN L
KENNEDY H
THORNTON T
KEREIAKES D
MARTIN L
ANDERSON L
HIGBY N
ELLIS S
BREZINA K
GEORGE B
CHAPEKIS A
SMITH D
ANWAR A
GERBER TL
PRITCHARD GL
MYLER R
SHAW R
MURPHY M
WARD K
MADIGAN NP
BLANKENSHIP J
HALBERT M
FLANAGAN C
TANNENBAUM M
POLICH M
STEVENSON C
TCHENG J
HOFFMAN S
MOORE RM
SMITH J
HENRY P
MCDONOUGH TJ
WESZT S
BRODIE B
MUNCY D
KLEIMAN N
TRAINOR K
ROSE D
JOHNSON S
WILLERSON J
FERGUSON JJ
HARLAN M
BASS TA
ROHMAN G
BROWNE K
CIESLA C
WORLEY S
TUZI J
HETTLEMAN B
BURKE WC
OLSEN G
KENNEDY SJ
TALLEY JD
YUSSMAN ZA
RAWERT M
GRASSMAN ED
WRONA L
SAMAHA J
EHEMANN B
BLEICH SD
LEONHARD R
CUMMINS F
NONNWEILER J
SANZ M
MAYER D
CLEMAN MW
PASCALE VJ
MCCONNELL S
DELCORE M
STENGEL L
IVANHOE RJ
GRANGER N
ROSENBERG MJ
SCHAECHTER A
AYCOCK G
WILCOX T
GOTTLIEB R
HUNTER H
UNTERECKER W
HART B
HEUSER R
HOOPMANN S
HANOVICH G
ANTOLICK A
GACIOCH G
CHIODO V
KARSKI K
TIMMIS G
SAFIAN M
AGUIRRE F
STONNER T
TAYLOR GJ
WOMACK K
RUYLE B
KRAUTHAMER D
WELCOM G
WESTON M
DILLON K
FRENCH WJ
REYNOLDS GT
NAVETTA F
MURPHY G
LEBOEUF R
SPENCER S
POPMA JJ
SWEET L
TOPOL EJ
SMITH CR
WEISMAN H
LEE KL
MILLER J
SIGMON K
TCHENG J
LEE KL
LUI M
KOSLOFF A
DIFULVIO J
WANG AL
ANDERSON K
WEISMAN H
DANN R
KINGMA W
NORTON D
MYER B
MASEK R
LEWANDOWSKI M
BRODERICK S
MUSCO M
SCHORR M
HARTMAN P
MCCARDLE L
FAXON D
ARMSTRONG P
GORE J
LOSCALZO J
MCCULLOUGH L
VERTER J
MARK DB
DAVIDSONRAY L
CLAPPCHANNING N
LAM LC
WAUGH RA
MCCANTS CB
HINDMAN MC
DEHMER G
HILLEGASS WB
FRID DJ
FORTIN DF
BROTT BC
FOREST TL
UNKS DM
HAMER ME
WAGNER GS
GATES K
SANE D
Citation: Rm. Califf et al., USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY/, The New England journal of medicine, 330(14), 1994, pp. 956-961